Covance Opens Biorepository in Indiana

Thursday, June 24, 2010 08:51 AM

Covance, a global contract research organization (CRO), has opened a state-of-the-art biorepository facility at its Greenfield, Ind. location.

The 20,000-square-foot building is dedicated to long-term storage of clinical trial specimens. The facility is able to store a wide-range of specimens, including plasma, serum, whole blood, DNA, PBMC and tissue.

Covance, through its central laboratory, has stored and managed patient specimens for the past 20 years, and the opening of this new facility further enhances the company’s ability to keep client specimens safe and secure.

“We believe Covance has the latest technology and capacity to meet our clients’ sample storage and testing needs for many years to come,” said Deborah Tanner, corporate senior vice president and president, Central Laboratory Services and Discovery & Translational Services. “By adding this biorepository to our existing central laboratory facilities, we are able to quickly store samples from our central labs and biomarkers work as well as samples from other sources.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs